Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs BioAge Labs, Inc. (BIOA)

ADC Therapeutics SA and BioAge Labs, Inc. are both Drug Manufacturers Specialty & Generic companies. BioAge Labs, Inc. is the larger, with a market value of $254.3M against $209.4M — 1.2× the size. ADC Therapeutics SA has the higher net margin (−121.8% vs −1,253.6%) and the higher return on invested capital (0.00% vs −21.8%). Across the 15 metrics below, ADC Therapeutics SA leads on 10 and BioAge Labs, Inc. on 5.

Valuation

Metric ADCT BIOA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 3.23 29.58 2.08
P/B n/m 0.73 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 0.52 12.22
EV/Sales 1.95 (7.23) 2.87
Earnings yield (39.76%) (46.03%) (15.94%)
Free cash flow yield (39.53%) (101.34%) 0.00%

Profitability

Metric ADCT BIOA Drug Manufacturers Specialty & Generic median
Gross margin 88.86% 100.00% 53.51%
Operating margin (125.08%) (1,401.81%) 0.00%
Net margin (121.77%) (1,253.60%) (2.45%)
Free cash flow margin (127.72%) (2,997.41%) 0.00%
Return on equity 45.35% (34.56%) (0.80%)
Return on assets (32.25%) (32.05%) (1.67%)
Return on invested capital 0.00% (21.75%) 0.00%

Growth

Metric ADCT BIOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 3.03% — 5.22%
EPS growth (last fiscal year) 30.86% 66.21% 42.91%
Revenue growth, 5-year CAGR 103.35% — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ADCT BIOA Drug Manufacturers Specialty & Generic median
Debt to equity (0.51) 0.00 0.04
Current ratio 3.03 15.51 2.41
Net debt to EBITDA 1.22 3.01 1.01

Dividend

Metric ADCT BIOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ADCT BIOA Drug Manufacturers Specialty & Generic median
Market cap 209.38m 254.27m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack